Drugs / Imidapril
Imidapril
also known as
Hipertene · Imidapril hcl · Imidapril hydrochloride · Imidapril monohydrochloride · TA 6366 · Tanatril
Small molecule targets ACE via inhibition
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01230034 | Oct 2010 → Jun 2011 | hypertensive disorder, proteinuria, type 2 diabetes mellitus | University of Pavia | Unknown | No outcome recorded |
| Phase 3 | NCT00644475 | Mar 2008 | essential hypertension | University of Pavia | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00890279 Comparator | Jul 2009 → Jun 2010 | autosomal dominant polycystic kidney disease | Ministry of Health, Labour and Welfare, Japan | Unknown | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Imidapril | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00890279 ↗ |
| Known as | Hipertene | ChEMBL registry synonym — accepted as the source's own label CHEMBL317094 ↗ |
| Known as | Imidapril hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL317094 ↗ |
| Known as | Imidapril hydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL317094 ↗ |
| Known as | Imidapril monohydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL317094 ↗ |
| Known as | TA 6366 | ChEMBL registry synonym — accepted as the source's own label CHEMBL317094 ↗ |
| Known as | Tanatril | ChEMBL registry synonym — accepted as the source's own label CHEMBL317094 ↗ |
| Action | Inhibit | “Angiotensin-converting enzyme inhibitor” CHEMBL317094 ↗ |
| Modality | Small molecule | — CHEMBL317094 ↗ |
| Route | Oral | “pill” NCT01230034 ↗ |
| Target | ACE | “Angiotensin-converting enzyme inhibitor” CHEMBL317094 ↗ |